Testsealabs CEA Carcinoembryonic Antigen Test
Inkcazelo emfutshane:
 Iziphumo eziKhawulezayo: ILab-Chanekile kwiMizuzu | Ukuchaneka kweBanga leLebhu: ethembekileyo kwaye ethembekileyo |
| Vavanya naphi na: Akukho tyelelo lwaseLab olufunekayo | Umgangatho oqinisekisiweyo: 13485, CE, iMdsap iyahambelana |
| Ilula kwaye iSetyenzisiwe: Kulula ukuyisebenzisa, iZero Hassle | ULulelo olugqibeleleyo: Vavanya ngokukhululeka ekhaya |
I-Carcinoembryonic Antigen (CEA)
I-CEA yi-cell surface glycoprotein enobunzima obumalunga nama-20,000. Uphando olongezelelweyo lubonise ukuba i-CEA inokubakho kwiintlobo zomhlaza ezingaphaya komhlaza we-colorectal, kubandakanya i-pancreatic, gastric, lung, kunye nomhlaza wamabele, phakathi kwabanye. Iimali ezincinci nazo zibonakaliswe kwiimfihlo ezivela kwi-colonic mucosa.
Ukuphakama okuzingileyo ekujikelezeni kwe-CEA kulandelayo unyango lubonisa ngokumandla kwi-occult metastatic kunye / okanye isifo esishiyekileyo. Ukunyuka ngokuqhubekayo kwexabiso le-CEA kunokunxulunyaniswa nesifo esiyingozi esiqhubekayo kunye nempendulo engalunganga yonyango. Ngokuchaseneyo, ukuhla kwexabiso le-CEA ngokuqhelekileyo kubonisa i-prognosis efanelekileyo kunye nempendulo efanelekileyo kunyango.
Umlinganiselo we-CEA ubonakaliswe ukuba ufanelekile ngokweklinikhi kulawulo olulandelwayo lwezigulane ezine-colorectal, isifuba, imiphunga, i-prostatic, i-pancreatic, i-ovarian kunye nezinye i-carcinomas. Uphononongo olulandelelweyo lwezigulane ezine-colorectal, ibele, kunye ne-lung carcinomas lucebisa ukuba inqanaba le-CEA langaphambi kokuhlinzwa linokubaluleka kwangaphambili.
Uvavanyo lwe-CEA alukhuthazwa njengenkqubo yokuhlola ukufumanisa umhlaza kubantu ngokubanzi; nangona kunjalo, ukusetyenziswa kovavanyo lwe-CEA njengovavanyo oluncedisayo kwi-prognosis kunye nokulawulwa kwezigulane zomhlaza kwamkelwa ngokubanzi.
Ubuncinci benqanaba lokufumanisa ngu-5 ng / mL.
